Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly Chibale

Showing results (201-210 of 315) with videos related to

Pageof 32
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 26, 2013
Synthesis of 2-aminomethyl-4-phenyl-1-azabicyclo[2.2.1]heptanes via LiAlH₄-induced reductive cyclization of 2-(4-chloro-2-cyano-2-phenylbutyl)aziridines and evaluation of their antimalarial activityMatthias D'hooghe, Karel Vervisch, Karl W Törnroos, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2016
Synthesis and biological characterisation of ester and amide derivatives of fusidic acid as antiplasmodial agentsMarlene Espinoza-Moraga, Kawaljit Singh, Mathew Njoroge, et al.
Beilstein Journal of Organic Chemistry|January 13, 2012
Synthesis of 2-amino-3-arylpropan-1-ols and 1-(2,3-diaminopropyl)-1,2,3-triazoles and evaluation of their antimalarial activityMatthias D'hooghe, Stéphanie Vandekerckhove, Karen Mollet, et al.
Journal of Medicinal Chemistry|August 31, 2011
Quinoline antimalarials containing a dibemethin group are active against chloroquinone-resistant Plasmodium falciparum and inhibit chloroquine transport via the P. falciparum chloroquine-resistance transporter (PfCRT)Vincent K Zishiri, Mukesh C Joshi, Roger Hunter, et al.
Journal of Medicinal Chemistry|April 20, 2011
Enone- and chalcone-chloroquinoline hybrid analogues: in silico guided design, synthesis, antiplasmodial activity, in vitro metabolism, and mechanistic studiesEric M Guantai, Kanyile Ncokazi, Timothy J Egan, et al.
Chemmedchem|July 12, 2019
Azaaurones as Potent Antimycobacterial Agents Active against MDR- and XDR-TBAndré Campaniço, Marta P Carrasco, Mathew Njoroge, et al.
Bioorganic & Medicinal Chemistry|January 27, 2018
Reversed isoniazids: Design, synthesis and evaluation against Mycobacterium tuberculosisMalkeet Kumar, Kawaljit Singh, Andile H Ngwane, et al.
Antimicrobial Agents and Chemotherapy|February 23, 2021
Developing synergistic drug combinations to restore antibiotic sensitivity in drug-resistant <i>Mycobacterium tuberculosis</i>Charles Omollo, Vinayak Singh, Elizabeth Kigondu, et al.
Antimicrobial Agents and Chemotherapy|December 9, 2015
New Verapamil Analogs Inhibit Intracellular Mycobacteria without Affecting the Functions of Mycobacterium-Specific T CellsGetahun Abate, Peter G Ruminiski, Malkeet Kumar, et al.
Biochemical Pharmacology|May 21, 2011
Effects of highly active novel artemisinin-chloroquinoline hybrid compounds on β-hematin formation, parasite morphology and endocytosis in Plasmodium falciparumTzu-Shean Feng, Eric M Guantai, Margo Nell, et al.
Pageof 32

Showing results (201-210 of 315) with videos related to

Sort By:
Pageof 32
Bioorganic & Medicinal Chemistry Letters|January 26, 2013
Synthesis of 2-aminomethyl-4-phenyl-1-azabicyclo[2.2.1]heptanes via LiAlH₄-induced reductive cyclization of 2-(4-chloro-2-cyano-2-phenylbutyl)aziridines and evaluation of their antimalarial activityMatthias D'hooghe, Karel Vervisch, Karl W Törnroos, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2016
Synthesis and biological characterisation of ester and amide derivatives of fusidic acid as antiplasmodial agentsMarlene Espinoza-Moraga, Kawaljit Singh, Mathew Njoroge, et al.
Beilstein Journal of Organic Chemistry|January 13, 2012
Synthesis of 2-amino-3-arylpropan-1-ols and 1-(2,3-diaminopropyl)-1,2,3-triazoles and evaluation of their antimalarial activityMatthias D'hooghe, Stéphanie Vandekerckhove, Karen Mollet, et al.
Journal of Medicinal Chemistry|August 31, 2011
Quinoline antimalarials containing a dibemethin group are active against chloroquinone-resistant Plasmodium falciparum and inhibit chloroquine transport via the P. falciparum chloroquine-resistance transporter (PfCRT)Vincent K Zishiri, Mukesh C Joshi, Roger Hunter, et al.
Journal of Medicinal Chemistry|April 20, 2011
Enone- and chalcone-chloroquinoline hybrid analogues: in silico guided design, synthesis, antiplasmodial activity, in vitro metabolism, and mechanistic studiesEric M Guantai, Kanyile Ncokazi, Timothy J Egan, et al.
Chemmedchem|July 12, 2019
Azaaurones as Potent Antimycobacterial Agents Active against MDR- and XDR-TBAndré Campaniço, Marta P Carrasco, Mathew Njoroge, et al.
Bioorganic & Medicinal Chemistry|January 27, 2018
Reversed isoniazids: Design, synthesis and evaluation against Mycobacterium tuberculosisMalkeet Kumar, Kawaljit Singh, Andile H Ngwane, et al.
Antimicrobial Agents and Chemotherapy|February 23, 2021
Developing synergistic drug combinations to restore antibiotic sensitivity in drug-resistant <i>Mycobacterium tuberculosis</i>Charles Omollo, Vinayak Singh, Elizabeth Kigondu, et al.
Antimicrobial Agents and Chemotherapy|December 9, 2015
New Verapamil Analogs Inhibit Intracellular Mycobacteria without Affecting the Functions of Mycobacterium-Specific T CellsGetahun Abate, Peter G Ruminiski, Malkeet Kumar, et al.
Biochemical Pharmacology|May 21, 2011
Effects of highly active novel artemisinin-chloroquinoline hybrid compounds on β-hematin formation, parasite morphology and endocytosis in Plasmodium falciparumTzu-Shean Feng, Eric M Guantai, Margo Nell, et al.
Pageof 32